3245 results
Keyword Sinemet RM Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Ronapreve
casirivimab, imdevimab, COVID-19 virus infection
Date of authorisation: 12/11/2021,
, Revision: 5, Authorised, Last updated: 10/07/2023
-
List item
Human medicine European public assessment report (EPAR): Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)
formoterol fumarate dihydrate, glycopyrronium, Beclometasone dipropionate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 23/04/2018, Revision: 4, Authorised, Last updated: 30/06/2023 -
List item
Human medicine European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis)
pemetrexed diacid monohydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016, Revision: 14, Authorised, Last updated: 17/10/2023h-4109-rmpsummary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Prevymis
Letermovir, Cytomegalovirus Infections
Date of authorisation: 08/01/2018,
, Revision: 15, Authorised, Last updated: 20/06/2023
-
List item
Human medicine European public assessment report (EPAR): Plenadren
hydrocortisone, Adrenal Insufficiency
Date of authorisation: 03/11/2011, Revision: 14, Authorised, Last updated: 13/10/2023 -
List item
Human medicine European public assessment report (EPAR): Lyfnua
Gefapixant, Cough
Date of authorisation: 15/09/2023,, Authorised, Last updated: 10/10/2023
-
List item
Human medicine European public assessment report (EPAR): Duloxetine Mylan
duloxetine, Neuralgia; Diabetic Neuropathies; Depressive Disorder, Major; Anxiety Disorders
Date of authorisation: 19/06/2015,
, Revision: 18, Authorised, Last updated: 25/08/2023
h-3981-rmpsummary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Aquipta
atogepant, Migraine Disorders
Date of authorisation: 11/08/2023,, Authorised, Last updated: 25/08/2023
icon application/pdf h-5871-rmp_en.pdf 25/08/2023 Generic This EPAR … -
List item
Human medicine European public assessment report (EPAR): Ebilfumin
oseltamivir, Influenza, Human
Date of authorisation: 22/05/2014,, Revision: 15, Authorised, Last updated: 01/06/2023
h-3717-rmpsummary_en.pdf … the risk management plan (RMP) for EBILFUMIN 30 mg, 45 … referred to as Ebilfumin). The RMP details important risks of … -
List item
Human medicine European public assessment report (EPAR): Brinavess
Vernakalant hydrochloride, Atrial Fibrillation
Date of authorisation: 01/09/2010, Revision: 16, Authorised, Last updated: 03/03/2022accordingly. Update of the RMP to version 7.0 to incorporate … a category 3 study in the RMP (PASS Protocol 6621- 049 … -
List item
Human medicine European public assessment report (EPAR): Sancuso
granisetron, Vomiting; Cancer
Date of authorisation: 20/04/2012, Revision: 14, Authorised, Last updated: 29/03/2023icon application/pdf h-2296-rmp_summary_en.pdf 16/06/2020 29/03/2023 Generic … -
List item
Human medicine European public assessment report (EPAR): Bretaris Genuair
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,, Revision: 18, Authorised, Last updated: 05/01/2023
icon application/pdf h-2706-rmp_summary_en.pdf 02/07/2021 02/07/2021 Generic … -
List item
Human medicine European public assessment report (EPAR): Scenesse
afamelanotide, Protoporphyria, Erythropoietic
Date of authorisation: 22/12/2014,, , 
, Revision: 9, Authorised, Last updated: 04/11/2022
h-2548-rmpsummary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Rubraca (updated)
rucaparib camsylate, Ovarian Neoplasms
Date of authorisation: 23/05/2018,
, , Revision: 15, Authorised, Last updated: 30/11/2023
-
List item
Human medicine European public assessment report (EPAR): Praluent (updated)
Alirocumab, Dyslipidemias
Date of authorisation: 23/09/2015, Revision: 21, Authorised, Last updated: 30/11/2023icon application/pdf h-3882-rmp_summary_en.pdf 01/10/2015 17/02/2022 Generic … -
List item
Human medicine European public assessment report (EPAR): Oyavas (updated)
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Uterine Cervical Neoplasms
Date of authorisation: 26/03/2021,, 
, Revision: 6, Authorised, Last updated: 09/11/2023
-
List item
Human medicine European public assessment report (EPAR): Omidria (updated)
ketorolac, phenylephrine, Lens Implantation, Intraocular; Pain, Postoperative
Date of authorisation: 28/07/2015, Revision: 9, Authorised, Last updated: 29/11/2023summary_of_rmp_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Nuceiva (updated)
Botulinum toxin type A, Skin Aging
Date of authorisation: 27/09/2019,, Revision: 5, Authorised, Last updated: 29/11/2023
-
List item
Human medicine European public assessment report (EPAR): Pepaxti (updated)
Melphalan flufenamide hydrochloride, Multiple Myeloma
Date of authorisation: 17/08/2022, Revision: 3, Authorised, Last updated: 29/11/2023 -
List item
Human medicine European public assessment report (EPAR): Orgovyx (updated)
relugolix, Prostatic Neoplasms
Date of authorisation: 29/04/2022,, Revision: 8, Authorised, Last updated: 29/11/2023
icon application/pdf h-5353-rmp-summary_en.pdf 10/05/2022 … -
List item
Human medicine European public assessment report (EPAR): Riltrava Aerosphere (updated)
Budesonide, formoterol fumarate dihydrate, Glycopyrronium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 06/01/2022, Revision: 3, Authorised, Last updated: 28/11/2023 -
List item
Human medicine European public assessment report (EPAR): Zessly (updated)
infliximab, Arthritis, Psoriatic; Psoriasis; Crohn Disease; Arthritis, Rheumatoid; Colitis, Ulcerative; Spondylitis, Ankylosing
Date of authorisation: 18/05/2018,, Revision: 12, Authorised, Last updated: 28/11/2023
-
List item
Human medicine European public assessment report (EPAR): Betaferon (updated)
interferon beta-1b, Multiple Sclerosis
Date of authorisation: 30/11/1995, Revision: 36, Authorised, Last updated: 24/11/2023 -
List item
Human medicine European public assessment report (EPAR): Zabdeno (updated)
Recombinant Adenovirus type 26 (Ad26) encoding the glycoprotein (GP) of the Ebola virus Zaire (ZEBOV) Mayinga strain, Hemorrhagic Fever, Ebola
Date of authorisation: 01/07/2020,, , Revision: 5, Authorised, Last updated: 24/11/2023
-
List item
Human medicine European public assessment report (EPAR): Mvabea (updated)
Recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP); Ebola virus Sudan Gulu strain GP; Ebola virus Taï Forest strain nucleoprotein and the Marburg virus Musoke strain GP, Hemorrhagic Fever, Ebola
Date of authorisation: 01/07/2020,, , Revision: 4, Authorised, Last updated: 24/11/2023